Nextgen Biomed Ltd
Tel Aviv Stock Exchange NXGN.TA
Nextgen Biomed Ltd Interest Coverage Ratio for the year ending December 31, 2023
Nextgen Biomed Ltd Interest Coverage Ratio is NA for the year ending December 31, 2023. Interest coverage ratio assesses earnings' ability to cover interest expenses; higher ratios signal lower risk.
-
Nextgen Biomed Ltd Interest Coverage Ratio for the year ending December 31, 2022 was -133.06, a -15.71% change year over year.
-
Nextgen Biomed Ltd Interest Coverage Ratio for the year ending December 31, 2021 was -115.00, a 91.13% change year over year.
-
Nextgen Biomed Ltd Interest Coverage Ratio for the year ending December 31, 2020 was -1,297.00, a -4.51% change year over year.
-
Nextgen Biomed Ltd Interest Coverage Ratio for the year ending December 31, 2019 was -1,241.00, a -5,946.16% change year over year.
Key data
| Date | Interest Coverage Ratio | Debt to Equity Ratio | Interest Expense To Sales | Inventory Turnover Ratio |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXGN.TA
| CEO | Mr. Harel Hershtik |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | 132 Azrieli Towers Round Building |
| Employees | 5 |
| Sector | Health Care |
| Industries | |
Description
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email